Zacks Research Comments on Medifast’s Q1 Earnings (NYSE:MED)

Medifast, Inc. (NYSE:MED) – Investment analysts at Zacks Research boosted their Q1 2025 earnings estimates for shares of Medifast in a report released on Monday, March 10th. Zacks Research analyst R. Department now expects that the specialty retailer will post earnings of ($0.07) per share for the quarter, up from their previous forecast of ($0.10). The consensus estimate for Medifast’s current full-year earnings is $0.51 per share. Zacks Research also issued estimates for Medifast’s Q4 2025 earnings at $0.53 EPS, FY2025 earnings at $1.04 EPS, Q3 2026 earnings at $0.39 EPS and Q4 2026 earnings at $0.49 EPS.

Separately, DA Davidson decreased their price target on shares of Medifast from $17.00 to $16.50 and set a “neutral” rating on the stock in a report on Wednesday, February 19th.

Medifast Stock Performance

Medifast stock opened at $13.93 on Thursday. The stock has a fifty day moving average of $15.18 and a 200-day moving average of $17.39. The stock has a market capitalization of $152.32 million, a P/E ratio of 77.37 and a beta of 1.13. Medifast has a 52 week low of $13.57 and a 52 week high of $39.14.

Medifast (NYSE:MED) last issued its quarterly earnings results on Tuesday, February 18th. The specialty retailer reported $0.10 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.16) by $0.26. Medifast had a return on equity of 10.64% and a net margin of 0.35%. The business had revenue of $119.00 million for the quarter, compared to the consensus estimate of $114.25 million.

Institutional Trading of Medifast

A number of hedge funds have recently made changes to their positions in MED. Wells Fargo & Company MN increased its position in Medifast by 23.5% in the 4th quarter. Wells Fargo & Company MN now owns 6,459 shares of the specialty retailer’s stock valued at $114,000 after acquiring an additional 1,227 shares during the period. Quarry LP raised its position in shares of Medifast by 148.6% during the third quarter. Quarry LP now owns 6,629 shares of the specialty retailer’s stock worth $127,000 after acquiring an additional 3,962 shares during the last quarter. Public Employees Retirement System of Ohio lifted its stake in shares of Medifast by 1,161.8% in the 3rd quarter. Public Employees Retirement System of Ohio now owns 9,766 shares of the specialty retailer’s stock valued at $187,000 after purchasing an additional 8,992 shares during the period. State of Wyoming grew its stake in Medifast by 286.1% during the fourth quarter. State of Wyoming now owns 11,312 shares of the specialty retailer’s stock worth $199,000 after purchasing an additional 8,382 shares during the period. Finally, Nisa Investment Advisors LLC increased its holdings in Medifast by 2,308.8% in the fourth quarter. Nisa Investment Advisors LLC now owns 11,442 shares of the specialty retailer’s stock worth $202,000 after purchasing an additional 10,967 shares in the last quarter. 95.51% of the stock is owned by institutional investors and hedge funds.

About Medifast

Medifast, Inc, through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names.